The development and validation of HPLC-DMD method for intermediate products impurities determination of morpholinium 2-((4-(2-methoxyphenyl)-5-(pyridine-4-yl)-4H-1,2,4-triazole-3-yl)thio)acetate in bulk drug
Purpose. A development and validation of new sensitive, high efficient and selective HPLC determination method of intermediates technological contaminations in bulk drug of morpholin-4-ium 2-((4-(2-methoxyphenyl)-5-(pyridine-4-yl)-4H-1,2,4-triazole-3-yl)thio)acetate (active pharmaceutical ingredient...
Main Authors: | B. O. Varynskyi, A. G. Kaplaushenko |
---|---|
Format: | Article |
Language: | English |
Published: |
Zaporozhye State Medical University
2017-06-01
|
Series: | Zaporožskij Medicinskij Žurnal |
Subjects: | |
Online Access: | http://zmj.zsmu.edu.ua/article/view/100947/97449 |
Similar Items
-
Metabolism study of morpholinium 2- ((4- (2-methoxyphenyl)-5-(pyridin-4-yl) -4H-1,2,4-triazole-3-yl)thio) acetate
by: Varynskyi Borys, et al.
Published: (2020-06-01) -
The HPLC-MS determination of pharmacokinetic parameters of morpholinium 2-((4-(2-methoxyphenyl)-5-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl)thio)acetate
by: Borys O. Varynskyi
Published: (2020-09-01) -
The thermodynamic study of morpholinium 2-((4-(2-methoxyphenyl)-5-(pyridinyl)-4H-1,2,4-triazol-3-yl)thio)acetate and its technological impurities in hydrophilic chromatography
by: B. O. Varynskyi
Published: (2020-12-01) -
Development and validation of HPLC-DAD method of determination piperidinium 2-((5-(furan-2-yl)-4-phenyl-4H-1,2,4-triazol-3-yl)thio)acetate in 1 % solution
by: B. O. Varynskyi, et al.
Published: (2017-12-01) -
The development of HPLC-DAD method for determination of active pharmaceutical ingredient in the potassium 2-((4-amino-5-(morpholinomethyl)-4H-1,2,4-triazol-3-yl)thio) acetate substance
by: Shcherbyna Roman, et al.
Published: (2019-03-01)